Skip to Content

Promising Efficacy of Biologicals and Small Molecules for Microscopic Colitis

The study presented in this MEDtalk by Bram Verstockt aimed to evaluate the efficacy of advanced therapies in treating microscopic colitis, particularly in patients who are refractory to or dependent on budesonide, the only approved therapy with a high relapse rate and significant side effects.

Bram Verstockt

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top